AbCellera Biologics (ABCL) Asset Utilization Ratio (2021 - 2026)
AbCellera Biologics' Asset Utilization Ratio was 0.05 in Q2 2026, up 111.4% from 0.02 a year earlier but down 14.9% from the prior quarter.
Powered by 
Analysis
AbCellera Biologics (ABCL) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
For FY2025, Asset Utilization Ratio at AbCellera Biologics came in at 0.06, up 173.1% from FY2024.
- In earlier years, Asset Utilization Ratio was 0.02 in FY2024 (-19.4%), 0.03 in FY2023 (-92.6%), 0.34 in FY2022 (+5.2%) and 0.32 in FY2021.
- Quarterly Asset Utilization Ratio has moved between 0.02 (Q1 2025) and 0.38 (Q3 2022) over five years.
- Compared with a year earlier, Asset Utilization Ratio has increased for five straight quarters, with growth averaging 57.6% over the last eight quarters.
- The best year-over-year quarter for Asset Utilization Ratio over five years was Q1 2026 (growth of 247.9%); the worst was Q4 2023 (a decline of 91.9%).
- Per Business Quant data, ABCL's Asset Utilization Ratio in the three quarters before Q2 2026 was 0.06 (Q1 2026), 0.06 (Q4 2025) and 0.03 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | 0.44 |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 0.47 |
| 10 | AbCellera Biologics | 3.89 Bn | 3.89 Bn | - | 0.05 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.05 |
| Mar 31, 2026 | 0.06 |
| Dec 31, 2025 | 0.06 |
| Sep 30, 2025 | 0.03 |
| Jun 30, 2025 | 0.02 |
| Mar 31, 2025 | 0.02 |
| Dec 31, 2024 | 0.02 |
| Sep 30, 2024 | 0.02 |
| Jun 30, 2024 | 0.02 |
| Mar 31, 2024 | 0.02 |
| Dec 31, 2023 | 0.03 |
| Sep 30, 2023 | 0.03 |
| Jun 30, 2023 | 0.10 |
| Mar 31, 2023 | 0.12 |
| Dec 31, 2022 | 0.31 |
| Sep 30, 2022 | 0.38 |
| Jun 30, 2022 | 0.32 |
| Mar 31, 2022 | 0.34 |
| Dec 31, 2021 | 0.30 |
| Sep 30, 2021 | 0.38 |
API Access
AbCellera Biologics Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=ABCL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "ABCL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=ABCL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();